Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics
Condition(s):Second Generation Antipsychotic Induced Metabolic Adverse EffectsLast Updated:March 14, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Second Generation Antipsychotic Induced Metabolic Adverse EffectsLast Updated:March 14, 2013Completed
Condition(s):Adverse Drug EventLast Updated:May 20, 2020Recruiting
Condition(s):Mental DisordersLast Updated:May 3, 2018Completed
Condition(s):SchizophreniaLast Updated:November 16, 2016Unknown status
Condition(s):Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Psychotic Disorder, Not Otherwise Specified; Prodromal Schizophrenia; Mood Disorder; Bipolar Disorder; Major Depressive Disorder; Depressive Disorder, Not Otherwise Specified; Mood Disorder, Not Otherwise Specified; Autism Spectrum DisorderLast Updated:February 22, 2013Completed
Condition(s):SchizophreniaLast Updated:October 3, 2016Completed
Condition(s):Pediatric Population on Second Generation AntipsychoticsLast Updated:May 9, 2016Withdrawn
Condition(s):Schizophrenia; Psychotic Disorders; PsychosisLast Updated:July 10, 2019Unknown status
Condition(s):Schizophrenia; Psychotic DisordersLast Updated:April 27, 2015Completed
Condition(s):ObesityLast Updated:February 24, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.